Eulalia Valencia

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Preparing for the Next Physician's Visit: Usability and Validity of a Mobile Health App for People Living with HIV.

Preparing for the Next Physician's Visit: Usability and Validity of a Mobile Health App for People Living with HIV.

Journal: AIDS and behavior

Published: April 29, 2025

Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD.

Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD.

Journal: Biomedicines

Published: April 12, 2024

Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.

Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.

Journal: HIV medicine

Published: February 23, 2024

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.

Journal: The Journal of antimicrobial chemotherapy

Published: June 21, 2023

Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.

Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.

Journal: HIV medicine

Published: March 06, 2023

Mental Health in Children, Adolescents, and Youths Living with Perinatally Acquired HIV: At the Crossroads of Psychosocial Determinants of Health.

Mental Health in Children, Adolescents, and Youths Living with Perinatally Acquired HIV: At the Crossroads of Psychosocial Determinants of Health.

Journal: Children (Basel, Switzerland)

Published: December 20, 2022

Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients.

Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients.

Journal: AIDS (London, England)

Published: July 18, 2022

Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir-based dual therapy. Bi-lipid study.

Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir-based dual therapy. Bi-lipid study.

Journal: HIV medicine

Published: June 03, 2022

Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD.

Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD.

Journal: Frontiers in pharmacology

Published: May 10, 2022

Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens.

Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens.

Journal: Open forum infectious diseases

Published: January 11, 2022

Overview of virus and cancer relationships. Position paper.

Overview of virus and cancer relationships. Position paper.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: August 05, 2021

Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment.

Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment.

Journal: The Journal of infectious diseases

Published: May 05, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026